JPY 1154.0
(0.17%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 20 Million JPY | 0.0% |
2022 | 20 Million JPY | 0.0% |
2021 | 20 Million JPY | 0.0% |
2020 | 20 Million JPY | 0.0% |
2019 | 20 Million JPY | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q1 | 20 Million JPY | 0.0% |
2024 Q2 | 418 Million JPY | 0.0% |
2023 Q3 | 20 Million JPY | 0.0% |
2023 Q1 | 20 Million JPY | 0.0% |
2023 Q2 | 20 Million JPY | 0.0% |
2023 FY | 20 Million JPY | 0.0% |
2023 Q4 | 20 Million JPY | 0.0% |
2022 Q3 | 136 Million JPY | 0.0% |
2022 FY | 20 Million JPY | 0.0% |
2022 Q4 | 20 Million JPY | -85.29% |
2021 FY | 20 Million JPY | 0.0% |
2020 FY | 20 Million JPY | 0.0% |
2019 FY | - JPY | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
Shin Nippon Biomedical Laboratories, Ltd. | 26.33 Billion JPY | 99.924% |
DNA Chip Research Inc. | - JPY | -Infinity% |
H.U. Group Holdings, Inc. | 81.94 Billion JPY | 99.976% |
FALCO HOLDINGS Co., Ltd. | 817 Million JPY | 97.552% |
BML, Inc. | 5.26 Billion JPY | 99.62% |
Human Metabolome Technologies, Inc. | 226.3 Million JPY | 91.162% |
Precision System Science Co., Ltd. | 1.36 Billion JPY | 98.537% |